Recent Company News

• 04:11 AM ET May 23, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 09:16 AM ET Jul 28, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:22 AM ET Jul 28, 2025
  

  StreetAccount Summary - US Pre-market trading

• 06:22 AM ET Jul 28, 2025
  

  Innate Pharma initiated buy at BTIG ($2.03, 0.00)

• 04:58 PM ET Jul 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:58 AM ET Jul 16, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 11:41 PM ET Jul 15, 2025
  

  Innate Pharma transferred buy at Stifel; prior rating was buy (€1.50, 0.00)

• 01:01 AM ET Jun 13, 2025
  

  Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress (€1.71, 0.00)